Sodium in PDB 8tv2: Structure of Apo FABS1C_L1

The structure of Structure of Apo FABS1C_L1, PDB code: 8tv2 was solved by A.U.Singer, H.A.Bruce, L.Blazer, J.J.Adams, F.Sicheri, S.S.Sidhu, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	64.31 / 2.65
Space group	P 31 2 1
Cell size a, b, c (Å), α, β, γ (°)	74.259, 74.259, 370.837, 90, 90, 120
R / Rfree (%)	20.4 / 24.7

The structure of Structure of Apo FABS1C_L1 also contains other interesting chemical elements:

Chlorine

(Cl)

8 atoms

The binding sites of Sodium atom in the Structure of Apo FABS1C_L1 (pdb code 8tv2). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the Structure of Apo FABS1C_L1, PDB code: 8tv2:
Jump to Sodium binding site number: 1; 2;

Sodium binding site 1 out of 2 in the Structure of Apo FABS1C_L1


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Structure of Apo FABS1C_L1 within 5.0Å range: probe atom residue distance (Å) B Occ D:Na303 b:48.1 occ:1.00 OH D:TYR169 3.2 47.0 1.0 O D:HOH407 3.3 52.4 1.0 OE1 D:GLU172 3.3 71.3 1.0 N D:VAL174 3.4 54.2 1.0 CB D:GLU172 3.6 58.7 1.0 CA D:PRO173 3.6 52.2 1.0 CB D:ALA192 3.7 51.9 1.0 C D:PRO173 4.0 52.3 1.0 CD2 D:LEU202 4.1 43.4 1.0 CZ D:TYR169 4.1 51.3 1.0 CE2 D:TYR169 4.1 51.9 1.0 CG D:GLU172 4.2 60.9 1.0 CD D:GLU172 4.2 69.6 1.0 CB D:PRO173 4.3 47.2 1.0 CA D:GLU172 4.3 51.5 1.0 O D:VAL174 4.4 53.2 1.0 CA D:VAL174 4.4 53.4 1.0 CB D:VAL174 4.5 54.5 1.0 N D:PRO173 4.8 53.4 1.0 C D:VAL174 4.9 51.0 1.0

Sodium binding site 2 out of 2 in the Structure of Apo FABS1C_L1


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 2 of Structure of Apo FABS1C_L1 within 5.0Å range: probe atom residue distance (Å) B Occ B:Na302 b:68.5 occ:1.00 O B:ARG75 2.7 72.9 1.0 CB B:SER77 3.3 63.2 1.0 C B:ARG75 3.4 65.4 1.0 OG B:SER77 3.5 67.9 1.0 N B:SER77 3.6 62.7 1.0 OG B:SER92 3.7 72.4 1.0 O B:THR90 3.7 64.0 1.0 O B:SER74 3.7 72.4 1.0 C B:PHE76 3.7 64.1 1.0 CB B:SER92 3.8 70.4 1.0 N B:SER92 3.9 71.9 1.0 N B:PHE76 4.0 65.3 1.0 CA B:SER77 4.0 60.9 1.0 CA B:ARG75 4.1 69.0 1.0 CA B:PHE76 4.1 65.4 1.0 CG2 B:THR90 4.2 69.2 1.0 C B:THR90 4.2 66.4 1.0 O B:PHE76 4.3 66.5 1.0 CA B:SER92 4.3 73.5 1.0 CB B:THR90 4.5 70.5 1.0 C B:ILE91 4.7 69.1 1.0 C B:SER74 4.7 73.7 1.0 CA B:ILE91 4.8 69.2 1.0 N B:ILE91 4.8 67.1 1.0 N B:ARG75 4.9 75.2 1.0 CA B:THR90 5.0 67.0 1.0

J.J.Adams, H.A.Bruce, L.Ploder, J.Garcia, G.Khutoreskaya, N.Jarvik, L.E.Costa, M.Gorelik, I.Pot, F.Sicheri, L.L.Blazer, A.U.Singer, S.S.Sidhu. Synthetic Antibodies Targeting EPHA2 Induce Diverse Signaling-Competent Clusters with Differential Activation To Be Published.